Peripherally Inserted Central Catheter (PICC) Market Report 2026

Peripherally Inserted Central Catheter (PICC) Market Overview

• Peripherally Inserted Central Catheter (PICC) market size has reached to $1.07 billion in 2025 • Expected to grow to $1.32 billion in 2030 at a compound annual growth rate (CAGR) of 4.3% • Growth Driver: Impact Of Rising Chronic Diseases On The Peripherally Inserted Central Catheter (PICC) Market • Market Trend: Innovative Advances Peripherally Inserted Central Catheter (PICC) Insertion Devices Redefining Patient Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Peripherally Inserted Central Catheter (PICC) Market?

A peripherally inserted central catheter (PICC) is a long, thin, flexible tube inserted into a peripheral vein, typically in the arm, and advanced until the tip reaches a larger vein near the heart called the superior vena cava. It is commonly used in healthcare settings to provide long-term access to intravenous (IV) therapies such as chemotherapy, antibiotics, nutrition, and other medications. The main types of peripherally inserted central catheters (PICC) are devices such as power-injectable and non-power-injectable. Power-injectable peripherally inserted central catheters (PICCs) are a form of peripherally inserted central catheter that can administer a quicker infusion of fluids or medications to critically ill patients. They are categorized by lumen type into single, double, and triple-wit kit types, such as tip-placement kits and conventional kits. The end users include hospitals and clinics, ambulatory surgical centers, and catheterization laboratories.

What Is The Peripherally Inserted Central Catheter (PICC) Market Growth Forecast?

The peripherally inserted central catheter (picc) market size is expected to see steady growth in the next few years. It will grow to $1.32 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing demand for power-injectable and multi-lumen picc systems, rising usage of tip-placement kits to improve procedural accuracy, growing procedure volumes in ambulatory surgical centers, expanding application of piccs in home infusion and outpatient therapy, rising focus on reducing complications and improving long-term vascular access outcomes. Major trends in the forecast period include rising adoption of power-injectable picc lines for advanced diagnostic and therapeutic procedures, increasing utilization of multi-lumen piccs for complex long-term iv therapy, growing preference for tip-placement and navigation-assisted picc insertion kits, expansion of picc usage in oncology nutrition support and chronic infection management, increasing deployment of picc lines across hospitals ascs and catheterization laboratories.

Global Peripherally Inserted Central Catheter (PICC) Market Segmentation

1) By Device Type: Power-Injectable, Non-Power Injectable 2) By Lumen Type: Single, Double, Triple 3) By Kit Type: Tip-Placement Kit, Conventional Kit 4) By End User: Hospitals and Clinics, Ambulatory Surgical Centers, Catheterization Laboratories Subsegments: 1) By Power-Injectable PICCs: Single Lumen Power-Injectable PICCs, Double Lumen Power-Injectable PICCs, Triple Lumen Power-Injectable PICCs 2) By Non-Power Injectable PICCs: Single Lumen Non-Power Injectable PICCs, Double Lumen Non-Power Injectable PICCs, Triple Lumen Non-Power Injectable PICCs

What Is The Driver Of The Peripherally Inserted Central Catheter (PICC) Market?

The growing prevalence of chronic diseases is expected to propel the growth of the peripherally inserted central catheter market in the coming years. Chronic diseases refer to long-term health conditions that persist over an extended period and often progress slowly, such as cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, obesity, and oral diseases. Peripherally inserted central catheters (PICCs) are employed in chronic conditions to provide long-term intravenous access to drugs, fluids, parenteral nutrition, and blood draws. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of individuals aged 50 years and older having one or more chronic illnesses is projected to rise by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2022 in the United States. Therefore, the growing prevalence of chronic diseases is driving the growth of the peripherally inserted central catheter (PICC) industry.

Key Players In The Global Peripherally Inserted Central Catheter (PICC) Market

Major companies operating in the peripherally inserted central catheter (picc) market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, B. Braun Medical Ltd, Teleflex Incorporated, ICU Medical Inc., Cook Medical, AngioDynamics, Argon Medical, PFM Medical Inc., Poly Medicure Ltd., Kimal Plc, Utah Medical Products Inc., Martech Medical Products, NeoMedical, Medical Components Inc, DeltaMed Solutions Inc., Access Vascular Inc., Medi-Tech Devices, Footprint Medical Incorporated, Biowy Corporation, Husk Medical B.V., Medcomp, Vygon Ltd, Haolang Technology (Foshan) Limited Co. Ltd

Global Peripherally Inserted Central Catheter (PICC) Market Trends and Insights

Major companies operating in the peripherally inserted central catheter (PICC) market are focused on innovative technologies, such as peripherally inserted central catheter insertion devices, to better serve their customers with advanced features. Peripherally inserted central catheter insertion devices are medical instruments specifically designed for the placement of peripherally inserted central catheters (PICCs) to insert them into a peripheral vein, typically in the arm, and guide them through the vasculature until the tip reaches a larger vein near the heart. For instance, in May 2023, Teleflex Incorporated, a US-based medical device company, launched two new peripherally inserted central catheter insertion devices, the Arrow VPS Rhythm DLX Device and the NaviCurve Stylet. The VPS Rhythm DLX Device uses cardiac electrical activity to offer real-time catheter tip position information. The device also has an optional integrated ultrasonography with a catheter-to-vessel ratio tool that supports consistency in vessel measuring. This gadget, in conjunction with the Arrow PICC packed with the NaviCurve Stylet, provides new tip navigation or location technology. The VPS Rhythm DLX Device featuring TipTracker Technology removes the necessity for a confirmatory x-ray, allowing the physician to insert smoothly via ultrasound vascular evaluation, peripherally inserted central catheter navigation, and final tip verification in the bottom third of the superior vena cava.

What Are Latest Mergers And Acquisitions In The Peripherally Inserted Central Catheter (PICC) Market?

In September 2024, Access Vascular, Inc., a US-based medical technology company specializing in hydrophilic biomaterial catheters, entered into a strategic partnership with Capstone Health Alliance for an undisclosed amount. With this partnership, Access Vascular aims to expand the adoption of its MIMIX line of midline and PICC catheters across Capstone’s network of over 300 hospitals, health systems, and physician practices, improving vascular access outcomes and reducing catheter-related complications. Capstone Health Alliance is a US-based regional group purchasing organization supporting hospitals and healthcare providers through supply chain and value-based purchasing solutions.

Regional Outlook

North America was the largest region in the peripherally inserted central catheter (PICC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Peripherally Inserted Central Catheter (PICC) Market?

The peripherally inserted central catheter (PICC) market consists of sales of antimicrobial-coated peripherally inserted central catheters, ultrasound-guided peripherally inserted central catheters, radiopaque peripherally inserted central catheters, and MRI-compatible peripherally inserted central catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.